Chinese Drug Regulations in 15 Minutes Part 3: China GVP and Recall Regulations
2023/ 5/ 11
China Drug Regulation in 15 Minutes Part 1: Responsibilities of Marketing Authorization Holders
2023/ 5/ 11
OH-EBASHI LPC & PARTNERS
After logging in, you can download the materials
The Chinese pharmaceutical market, which is the world's second largest market, is expected to continue expanding in the future, and will continue to be an important market.
Therefore, this time, we will introduce the framework and the latest laws and regulations of China's pharmaceutical affairs in a total of three videos.In addition, we will explain the points that Japanese pharmaceutical companies and pharmaceutical-related companies that are exporting, locally producing and selling pharmaceuticals to China, or that have plans to do so, should be careful and prepare.The second theme is the "commercial bribery problem."
Only members can watch it.
Please refrain from registering at a law firm, in the same industry as our company, or with a free email address.
OH-EBASHI LPC & PARTNERS
You can download the document from the form below.
The Chinese pharmaceutical market, which is the world's second largest market, is expected to continue expanding in the future, and will continue to be an important market.
Therefore, this time, we will introduce the framework and the latest laws and regulations of China's pharmaceutical affairs in a total of three videos.In addition, we will explain the points that Japanese pharmaceutical companies and pharmaceutical-related companies that are exporting, locally producing and selling pharmaceuticals to China, or that have plans to do so, should be careful and prepare.The second theme is the "commercial bribery problem."
OH-EBASHI LPC & PARTNERS
Fumi Takatsuki Lawyer
Career
・1998: Graduated from Keio University Faculty of Law
・1998-1999: Chinese language training for one year at the Central Theater Academy in Beijing, China
・2000: Miike Sogo Law Office
・2003: Anderson, Mori & Tomotsune
・2004-2005: Anderson, Mori & Tomotsune Beijing Representative Office
・2006: Oh-Ebashi Law Office
・2009: Partner of Oh-Ebashi Law Office (current position)
Field
Major areas of expertise include corporate M&A, general legal affairs related to China and Asia, joint ventures and M&A centered on China, international transactions, international dispute resolution, withdrawal from overseas projects, crisis management and fraud investigations, from the perspective of the Japanese head office. specializes in domestic corporate legal affairs and support for Chinese subsidiary management.In particular, he has extensive experience in the fields of life sciences and healthcare (pharmaceuticals, medical devices, cosmetics, food, etc.).
Profile
Oh-Ebashi Law Office was established in 1981 under the spirit of "creating a good office" for people, society and the times.The name comes from the Oe Bridge, which is a national important cultural property that spans the Dojima River sandbank in Osaka. The Shanghai office was opened in 1995, the Tokyo office in 2002, and the Nagoya office in 2015. Currently, the Tokyo office and the Osaka office have grown to the same size, and the total number of lawyers is about 150 (foreign law office). (including solicitors) has become a comprehensive law firm.For about 40 years, we have been a comprehensive law firm that provides superior legal services to our clients in various fields.We will earnestly face what we should do in the midst of all the changes of the times, and we will continue to work tirelessly to be the best partner for our clients.
Download materials / inquiries
You can download or contact us from here.
Please select a category, enter the required items, and press the send button.
